| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |